RARE · Ultragenyx Pharmaceutical Inc. · Documents
$16.08
+0.43 (+2.75%)
At close · Oct 26
Return incl. dividend (before tax)
Market Cap
$1.54B
Shares
98.59M
Volume · Oct 26
3.02M
Avg daily vol (3M)
4.12M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2023-02-16 | — | |
| 8-K | — | 2023-01-06 | — | |
| 8-K | — | 2022-11-10 | — | |
| 10-Q | — | 2022-11-03 | 2022-09-30 | |
| 8-K | — | 2022-11-02 | — | |
| 8-K | — | 2022-10-28 | 2022-06-24 | |
| 8-K | — | 2022-09-15 | 2022-09-09 | |
| 10-Q | — | 2022-07-29 | 2022-06-30 | |
| 8-K | — | 2022-07-28 | — | |
| 8-K | — | 2022-07-18 | 2022-07-15 | |
| 8-K | — | 2022-07-14 | — | |
| 8-K | — | 2022-06-27 | 2022-06-24 | |
| 8-K | — | 2022-05-17 | — | |
| 10-Q | — | 2022-05-06 | 2022-03-31 | |
| 8-K | — | 2022-05-05 | — | |
| DEF 14A | — | 2022-04-28 | 2022-06-24 | |
| DEFA14A | — | 2022-04-28 | — | |
| 8-K | — | 2022-04-22 | 2022-04-18 | |
| 10-K | — | 2022-02-15 | 2021-12-31 | |
| 8-K | — | 2022-02-10 | — | |
| 8-K | — | 2022-01-10 | — | |
| 8-K | — | 2022-01-07 | — | |
| 10-Q | — | 2021-11-03 | 2021-09-30 | |
| 8-K | — | 2021-11-02 | — | |
| 8-K | — | 2021-10-07 | — | |
| 8-K | — | 2021-09-27 | — | |
| 10-Q | — | 2021-08-03 | 2021-06-30 | |
| 8-K | — | 2021-08-02 | — | |
| 8-K | — | 2021-06-30 | 2021-06-29 | |
| 8-K | — | 2021-06-25 | 2021-06-24 | |
| 8-K | — | 2021-06-10 | — | |
| 8-K | — | 2021-05-19 | — | |
| 8-K | — | 2021-05-14 | — | |
| 8-K | — | 2021-05-07 | — | |
| 10-Q | — | 2021-05-05 | 2021-03-31 | |
| 8-K | — | 2021-05-04 | — | |
| DEF 14A | — | 2021-04-29 | 2021-06-24 | |
| DEFA14A | — | 2021-04-29 | — | |
| 8-K | — | 2021-04-16 | 2021-04-12 | |
| S-3ASR | — | 2021-02-12 | — | |
| 10-K | — | 2021-02-12 | 2020-12-31 | |
| 8-K | — | 2021-02-11 | — | |
| 8-K | — | 2021-01-21 | — | |
| 8-K | — | 2021-01-11 | — | |
| 8-K | — | 2021-01-08 | — | |
| 8-K | — | 2020-12-17 | — | |
| 8-K | — | 2020-12-07 | 2020-12-05 | |
| 8-K | — | 2020-11-02 | 2020-10-28 | |
| 8-K | — | 2020-10-27 | — | |
| 10-Q | — | 2020-10-27 | 2020-09-30 |
Showing 101–150 of 171 filings
Key facts
CIK
1515673
CUSIP
90400D108
13F (30d)
26 filings
26 filers
Visit website
Investor relations